Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox
about
The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003Herpes zoster in Germany: quantifying the burden of diseaseUpdate on herpes zoster vaccination: a family practitioner's guideHerpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspectiveSimilar herpes zoster incidence across Europe: results from a systematic literature reviewVaccination against herpes zoster in developed countries: state of the evidenceReview of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project dataUniversal varicella vaccination: efficacy trends and effect on herpes zosterVaccination against Herpes Zoster and Postherpetic NeuralgiaVaricella zoster vaccines and their implications for development of HSV vaccinesHerpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United StatesRecommendations for the Management of Herpes ZosterCost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgiaSeven challenges for model-driven data collection in experimental and observational studies.Varicella and herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997-2004.Mining social mixing patterns for infectious disease models based on a two-day population survey in BelgiumVaricella vaccination in Europe - taking the practical approach.Prevention strategies for herpes zoster and post-herpetic neuralgiaImpact of varicella vaccine on varicella-zoster virus dynamicsAssessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands.Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox.The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster.Preventing varicella-zoster diseaseHerpes zoster vaccine for the elderly: boosting immunity.Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination.Varicella vaccination in England and Wales: cost-utility analysis.Increased seroprevalence of IgG-class antibodies against cytomegalovirus, parvovirus B19, and varicella-zoster virus in women working in child day care.Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary ReviewHerpes zoster surveillance using electronic databases in the Valencian Community (Spain).Varicella vaccination alters the chronological trends of herpes zoster and varicella.Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responsesParadigm shifting vaccines: prophylactic vaccines against latent varicella-zoster virus infection and against HPV-associated cancerSeroepidemiology of varicella-zoster virus in Korean adolescents and adults using fluorescent antibody to membrane antigen test.Trends in hospitalizations with primary varicella and herpes zoster during the prevaricella and initial postvaricella and herpes zoster vaccine eras, connecticut, 1994-2012.Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.Sero-Prevalence of Antibodies against Varicella Zoster Virus in Children under Seven-Years Old in 2012 in Tehran, Iran.Effectiveness of live varicella vaccine.Varicella zoster virus: vaccination and implications in children with renal failure.Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models.
P2860
Q21257242-D770D8C1-11A7-4E82-B8CE-0ADBC15A261DQ21261833-7A7F0E0C-4E00-417A-880A-2366A7AC3D96Q24635096-BCE46DD9-B159-424B-9490-FD66FAF1CE19Q26781940-27839B20-DD18-45C0-B3E1-5AC7E245251FQ26824836-9A139EFB-C6A4-459C-A675-E078A7BB62FFQ26862748-BFEFF968-CE5F-476C-BBE7-F3C5733FE102Q26863614-B5EA82E5-A423-4E16-9228-598FE3F4632DQ28269376-7E83E4A5-900D-4E04-A15E-AE661B10288CQ28276808-35B61114-87A6-4F6F-8977-4C80BFB8B813Q28280820-58D9E502-2807-42A7-A9B6-B39A43CDEC19Q28300462-292CDD3D-A10E-478B-9F4E-6EED236B4213Q28315869-39A7D4E5-28B1-4BF0-8AC2-41768037AD3CQ28468596-3287B364-23A3-4B62-AD9E-57DC7636EBF2Q30373408-77F08779-918B-4FB4-BA3A-5EB2566386ABQ33287811-6A4501F1-0D4B-4EA3-A424-783E34277AC3Q33401108-9E5B32A5-25AF-4234-977A-1AEC13A6E159Q33454919-2CB9E051-1282-4565-AEC7-C3D90FB7A414Q33562809-958EC23C-92D6-447B-84D7-E3E7B3296FDAQ33591264-6EB0F614-DB0B-4A3B-B8D1-8E1754A0E1F8Q33657323-BB293C51-6BA2-428F-8195-6A295B9CBB53Q33683179-42DDB5F6-A040-407D-8319-1697B96ED57AQ33703581-D10FCC09-F7F9-4810-856E-787F3C663C9DQ33719386-901EE930-17DA-4214-B560-C158AB0E2CACQ33956779-2B64C7D2-4EF9-4FE4-831E-CFBBD07EB395Q34158156-A58995E7-5E73-41DD-9B48-E046DAE5F8F5Q34263829-8E7B77F2-D02A-4E2C-8EEC-9B0AB614C72CQ34314923-B864E6DF-8667-4E82-A29C-07B76249BF51Q34683751-B5548D67-6D90-45F8-8C47-FC35AB429CD5Q34785366-1F811C10-8AA4-4D0D-9ACE-E762319E3444Q35008196-7FDC3222-FE76-427A-8C64-7F789F86E0DDQ35035512-E609F536-E3C2-4687-BEA9-783389C1DDCFQ35105463-4ADFAF94-2852-4417-B842-E2404E9C38FEQ35258843-DE83AEFB-D90C-45A5-8B84-AB85D7B37A28Q35559555-149B02C9-ABC5-4163-BB34-C43C638B5B86Q35628205-0C1DADC0-9652-4F6B-B614-63A04F4BB973Q35652212-A678A2EE-604B-4583-B215-6454F17DDD20Q35666726-942DB600-F705-4441-B397-C9530E84A230Q35681513-6D4D1990-16E3-4935-86D2-632D9FEAAD52Q35791770-A2BC6A28-97B9-4E1F-BB67-70F3451C6F91Q36149754-CE959FE8-50BF-42BC-BF20-DFB419BDB508
P2860
Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Exposure to varicella boosts i ...... vaccination against chickenpox
@ast
Exposure to varicella boosts i ...... vaccination against chickenpox
@en
Exposure to varicella boosts i ...... vaccination against chickenpox
@nl
type
label
Exposure to varicella boosts i ...... vaccination against chickenpox
@ast
Exposure to varicella boosts i ...... vaccination against chickenpox
@en
Exposure to varicella boosts i ...... vaccination against chickenpox
@nl
prefLabel
Exposure to varicella boosts i ...... vaccination against chickenpox
@ast
Exposure to varicella boosts i ...... vaccination against chickenpox
@en
Exposure to varicella boosts i ...... vaccination against chickenpox
@nl
P2093
P3181
P1433
P1476
Exposure to varicella boosts i ...... vaccination against chickenpox
@en
P2093
P3181
P356
10.1016/S0264-410X(02)00180-9
P407
P577
2002-06-01T00:00:00Z
2002-06-07T00:00:00Z